A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
Abroad (travel likely)RecruitingPHASE1
Conditions
Diabetes Mellitus, Type 2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Anaheim Clinical Trials ( Site 0006), Anaheim, California, United States
ProSciento Inc. ( Site 0001), Chula Vista, California, United States
Advanced Pharma CR, LLC ( Site 0003), Miami, Florida, United States
QPS-MRA, LLC ( Site 0004), South Miami, Florida, United States
Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0005), Springfield, Missouri, United States
Study leads
Medical Director
Study Director
Merck Sharp & Dohme LLC